Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger von Moos

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Case Reports in Neurology|November 30, 2011
Intravascular lymphoma mimicking cerebral stroke: report of two casesThomas Hundsberger, Sergio Cogliatti, Gian-Reto Kleger, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumorsVincent A de Weger, Sanjay Goel, Roger von Moos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 19, 2014
Patients' preferences for bone metastases treatments in France, Germany and the United KingdomGuy Hechmati, A Brett Hauber, Jorge Arellano, et al.
The Prostate|March 9, 2005
Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulationYing Waeckerle-Men, Edith Uetz-von Allmen, Roger von Moos, et al.
Investigational New Drugs|February 15, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a studyMarkus Joerger, Thomas Hundsberger, Simon Haefliger, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone diseaseIngo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
Journal of Bone Oncology|December 24, 2016
Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countriesJean-Jacques Body, Yves Pascal Acklin, Oliver Gunther, et al.
Journal of Bone Oncology|March 27, 2018
Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective studyRoger von Moos, Jean-Jacques Body, Oliver Guenther, et al.
Oncology|January 23, 2009
Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research studyThomas Ruhstaller, Roger von Moos, Kaspar Rufibach, et al.
Swiss Medical Weekly|February 23, 2016
The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanomaReinhard Dummer, Marco Siano, Robert E Hunger, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Case Reports in Neurology|November 30, 2011
Intravascular lymphoma mimicking cerebral stroke: report of two casesThomas Hundsberger, Sergio Cogliatti, Gian-Reto Kleger, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumorsVincent A de Weger, Sanjay Goel, Roger von Moos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 19, 2014
Patients' preferences for bone metastases treatments in France, Germany and the United KingdomGuy Hechmati, A Brett Hauber, Jorge Arellano, et al.
The Prostate|March 9, 2005
Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulationYing Waeckerle-Men, Edith Uetz-von Allmen, Roger von Moos, et al.
Investigational New Drugs|February 15, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a studyMarkus Joerger, Thomas Hundsberger, Simon Haefliger, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone diseaseIngo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
Journal of Bone Oncology|December 24, 2016
Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countriesJean-Jacques Body, Yves Pascal Acklin, Oliver Gunther, et al.
Journal of Bone Oncology|March 27, 2018
Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective studyRoger von Moos, Jean-Jacques Body, Oliver Guenther, et al.
Oncology|January 23, 2009
Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research studyThomas Ruhstaller, Roger von Moos, Kaspar Rufibach, et al.
Swiss Medical Weekly|February 23, 2016
The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanomaReinhard Dummer, Marco Siano, Robert E Hunger, et al.
Pageof 13